Your browser doesn't support javascript.
loading
Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells.
Yin, Li; Qi, Xiao-Wei; Liu, Xun-Zhou; Yang, Ze-Yu; Cai, Rui-Li; Cui, Hong-Juan; Chen, Li; Yu, Shi-Cang.
Affiliation
  • Yin L; Department of Stem Cell and Regenerative Medicine, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China.
  • Qi XW; Key Laboratory of Cancer Immunopathology, Ministry of Education, Chongqing 400038, P.R. China.
  • Liu XZ; Breast Disease Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China.
  • Yang ZY; State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, P.R. China.
  • Cai RL; Department of Stem Cell and Regenerative Medicine, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China.
  • Cui HJ; Key Laboratory of Cancer Immunopathology, Ministry of Education, Chongqing 400038, P.R. China.
  • Chen L; Department of Stem Cell and Regenerative Medicine, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China.
  • Yu SC; Key Laboratory of Cancer Immunopathology, Ministry of Education, Chongqing 400038, P.R. China.
Oncol Lett ; 19(6): 3950-3958, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32382339

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncol Lett Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncol Lett Year: 2020 Type: Article